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Abstract: Fetal alcohol syndrome (FAS) is a developmental neuropathology resulting from in utero exposure to ethanol; many 
of ethanol’s effects are likely to be mediated by the neurotransmitter γ-aminobutyric acid (GABA). We studied modulation 
of the neurotransmitter receptor GABABR and its capacity for intracellular signal transduction under conditions of ethanol 
treatment (ET) and RNA interference to investigate a potential role for GABA signaling in FAS. ET increased GABAB1R 
protein levels, but decreased protein kinase A-α (PKA-α), calcium/calmodulin-dependent protein kinase II (CaMKII) and 
phosphorylation of cAMP-response element binding protein (p-CREB), in cultured hippocampal neurons harvested at 
gestation day 17.5. To elucidate GABAB1R response to ethanol, we observed the effects of a GABABR agonist and antagonist in 
pharmacotherapy for ethanol abuse. Baclofen increased GABABR, CaMKII and p-CREB levels, whereas phaclofen decreased 
GABABR, CaMKII and p-CREB levels except PKA-α. Furthermore, when GABAB1R was knocked down by siRNA treatment, 
CaMKII and p-CREB levels were reduced upon ET. We speculate that stimulation of GABAB1R activity by ET can modulate 
CaMKII and p-CREB signaling to detrimental effect on fetal brain development.
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leading to developmental disorders, including central nervous 
system (CNS) dysfunction, neurobehavioral disruption, 
neurological deficits, and epilepsy [5, 6]. Among the major 
neuropathological changes of FAS, size of the hippocampus 
and other brain regions is reduced [2, 7], but the mechanism 
by which ethanol induces this damage in the prenatal 
hippocampus is not fully understood [8].
γ-aminobutyric acid (GABA), the principal inhibitory 
neurotransmitter, has been heavily investigated for a possible 
role in ethanol-mediated neuropathology. Previous work 
focused on the GABAAR chloride channel [9], which has 
been demonstrated to contribute to FAS [10]. The GABAB 
system, the predominant inhibitory metabotropic receptor 
Introduction
Exposure to ethanol during gestation induces abnor-
malities of structure and function on neuronal maturation, 
resulting in fetal alcohol syndrome (FAS) in the brain [1-
4]. FAS is a specific, recognizable pattern of malformation, 
resulting from exposure of the human fetus to ethanol and Ethanol-mediated stimulation of GABAB receptor
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in the mammalian CNS, has been less well characterized 
due to the limited number of pharmacologic agents that can 
interact with GABABR [11], which mediates slow inhibitory 
GABA synaptic neurotransmission through association with 
G proteins and through cAMP-dependent signaling [12, 
13]. Some studies have indicated that the GABABR agonist 
baclofen can reduce ethanol intake, although this may 
depend on the dose administered [14-17]. In addition, the 
GABABR antagonist phaclofen attenuates the coordinating 
and locomotor-activating effects produced by low doses of 
ethanol. Moreover, phaclofen reduces some of the behavioral 
alterations produced by anesthetic concentrations of ethanol 
[18]. RNA interference (RNAi) against the GABAB1R or 
treatment with the GABAB antagonist CGP 54626 reduces 
ethanol’s impairment of behavior, possibly implying a role 
for GABABR in mediating ethanol’s neurological effects 
[19]. Furthermore, the cAMP-signaling pathway is a major 
target of ethanol in the CNS [20]. It has been previously 
reported that the activation of protein kinase A (PKA) is 
likely to be responsible for cAMP response element binding 
protein (CREB) phosphorylation, and in the hippocampus, 
stimulation of adenylyl cyclase either by Ca
2+/calmodulin 
kinase (CaMKII) or by receptor-coupled G proteins increases 
intracellular concentrations of cAMP. Thus, the GABAB 
system may transduce ethanol’s effects [11].
In the present study, we used an agonist and an antagonist 
of GABABR, as well as siRNA treatment, to study the mo  du-
lation of GABAB1R, PKA-α, CaMKII, and p-CREB ex  pression 
in cultivated hippocampal neurons in vitro under ethanol 
treatment (ET).
Materials and Methods
Animal treatment
Female (n=30) Sparague-Dawley rats (250 g, Gyeongsang 
National University Neurobiology Laboratory, Jinju, Korea) 
were housed in a temperature-controlled environment with 
lights on from 6:00-20:00 h and food ad libitum. Pregnant rats 
were killed by ethyl ether anesthesia at gestational day (GD) 
17.5 of fetal development.
Primary hippocampal cell culture
Primary hippocampal cultures were prepared from brains 
of GD 17.5 fetuses. Hippocampal tissues were treated with 
0.25% trypsin-EDTA for 20 minutes and dissociated by 
mechanical trituration in ice-cold calcium- and magnesium-
free Hank's balanced salt solution. After pelleting by 
centrifugation, cells were plated (1×10
6 cells/ml) in cell 
culture plates pre-coated with poly-lysine (0.02 g/L) and 
cham  ber slides. The culture medium consisted of Dulbecco’s 
modified Eagle medium (DMEM) with 10% heat-inactivated 
fetal bovine serum, 1 mM pyruvate, 4.2 mM sodium bicar-
bonate, 20 mM HEPES, 0.3 g/L bovine serum albumin, 50 
U/ml penicillin, and 50 mg/L streptomycin. Cultures were 
maintained at 37°C in a humidified atmosphere with 5% CO2. 
Neuroglial cell proliferation was inhibited by treatment with 
growth medium containing 10 µM cytosine β-D-arabino 
furanoside (Sigma, St. Louis, MO, USA) for 12 hours.
siRNA transfection and drug treatment
GABAB1R cDNA was removed from pCI vector by XbaI 
and EcoRI digestion (provided by Novatis Pharma, Basel, 
Switzerland). The primer which contained T7 promoter 
region (forward: 5'-CGGTAATACGACTCACTATAGGGAG
ACGCTACCATCCAACAGACCA-3', reverse: 5'-GCGTAA 
TACGACTCACTATAGGGAGATCCTGTGAGCTCATGTT
GGAA-3') was used for amplification of cDNA of GABAB1R. 
Then dsRNAs were prepared with the MEGAscript
® RNAi 
kit (Ambion, Austin, TX, USA) by incubation at 37°C for 
4 hours. RNAi was performed by using a ShortCut RNAi 
Kit (New England Biolabs, Buckinghamshire, UK). For 
GABAB1R (420 bp) from 1,096 bp to 1,516 bp (accession no. 
NM 031028) with the highest silent activity was selected. One 
day before transfection, the medium was changed to DMEM 
without antibiotics and serum. Liposome solution (DMEM 
containing Lipofectamine2000
TM, Invitrogen, Carlsbad, CA, 
USA) and equal volume of dsRNA (21 bp as shortcut dsRNA) 
solution were incubated for 5 minutes at room temperature 
respectively, then combined together and incubated for 20 
minutes. The mixture was added to the culture medium in 
each plate to reach a final concentration of 20 nM. After 
48 hours of transfection, both cells with and without RNAi 
transfection transfer to the normal media as control, media 
contained 100 mM ethanol, 100 mM ethanol and 50 μM 
baclofen, 100 mM ethanol and 100 μM phaclofen, 100 mM 
ethanol and 50 μM baclofen plus 100 μM phaclofen. After 20 
minutes of drug treatment, the cells were harvested. And the 
transfection efficiency was confirmed by using a BLOCK-
iT
TM transfection kit (Invitrogen) containing a fluorescent 
oligonucleotide (100 mM) for siRNA transfection after 2 days.Anat Cell Biol 2011;44:210-217 Hae Young Lee, et al 212
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Reverse transcription polymerase chain reaction (RT-
PCR)
RT-PCR analysis was performed to identify cDNAs trans-
cribed in transfected or mock-transfected cultures. Total 
RNA was isolated with TRIzol Reagent (Life Technologies, 
Rockville, MD, USA). First strand cDNA was transcribed 
from 2 µg RNA using oligo (dT)15 and M-MLV reverse 
transcriptase (Promega, Madison, WI, USA) according 
to manufacturer’s instructions. A total of 4 µl cDNA were 
used for PCR amplification with 1 µl Taq DNA polymerase. 
Thermal cycling was performed under the following 
conditions: 94°C for 5 minutes; 30 cycles at 94°C, 68°C, and 
72°C for 1 minute each; final extension at 72°C for 5 minutes. 
A negative control PCR for β-actin was performed at 58°C 
for 25 cycles. PCR product was run out on a 1% agarose gel 
containing ethidium bromide and viewed under UV light. 
The primers used were the following:
 GABAB1R forward primer: 5'-AATTGAATTCCGCTACC
ATCCAACAGACCA-3';
 GABAB1R reverse primer: 5'-AATTAAGCTTTCCTGTG
ACGTCATGTTGGAA-3' 
Western blotting
Drug-treated hippocampal cells were homogenized in cell 
lysis buffer (Cell Signaling no. 9803, Danvers, MA, USA) for 
protein extraction. After two rounds of ultra-centrifugation 
at 12,000 rpm for 10 minutes (4°C), supernatant protein 
concentration was quantified using the Bio-Rad protein assay 
kit. Thirty µg soluble fraction were separated on duplicate 
12% sodium dodecyl sulfate (SDS)-polyacrylamide gels (30% 
acrylamide, 1% Bis, 1 M Tris, 20% SDS, 10% APS, TEMED). 
Proteins were transferred to polyvinylidene fluoride mem-
brane at 90 V for 1 hour (in electrotransfer buffer with 48 
mM Tris, 39 mM glycine, 20% MeOH, and 0.037% SDS). 
Membranes were treated with blocking solution (Tris-buffered 
saline containing 0.1% [v/v] Tween-20 and 6% [w/v] non-fat 
dry milk) to reduce non-specific binding. Immunostaining 
was carried out using a guinea-pig derived anti-rat GABAB1R 
(1 : 500, 24 hours, 4°C, Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), rabbit anti-rat PKA-α (1 : 500, Santa Cruz 
Biotechnology), rabbit anti-rat CaMKII (1 : 500, Cell Signaling) 
or rabbit anti-rat p-CREB (1 : 500, Cell Signaling). Anti-Actin 
antibody (1 : 1,000, Sigma-Aldrich, Jerusalem, Israel) was 
taken as control to confirm uniform loading. Anti  gen was 
detected by enhanced chemiluminescence (Western blotting 
detection reagents, Amersham Pharmacia Biotech, Piscataway, 
NJ, USA) according to manufacturer’s instructions. In some 
cases, the blots were stripped and re  probed. Briefly, after film 
exposure, washed membrane four times for 5 minutes each 
in TBST, then agitated gently the membrane in the antibody 
stripping solution (ReBlot Plus Strong Antibody stripping 
solution, Millipore, Temecula, CA, USA) at room temperature 
for 15 minutes. After that, again washed the membrane four 
times for minutes each in TBST, then reprobed with a rabbit 
antiactin (1 : 1,000, Sigma-Aldrich). Western blots were 
analyzed by densitometry using the computer-based Sigma 
Gel system (SPSS Inc., Chicago, IL, USA). Density values were 
expressed as mean±SEM. A Student’s t-test was performed to 
determine significant differences among groups. In each case, 
significance was accepted to be P<0.05.
Immunofluorescence assays
Immunofluorescence was performed on GD 17.5 primary 
hippocampal cell cultures grown in vitro on poly-L-lysine 
coated round glass coverslips. Cultures were fixed for 5 
minutes with 4% paraformaldehyde in phosphate buffered 
saline (PBS), permeabilized in 0.3% Triton X-100 in PBS for 5 
minutes, and rinsed twice in PBS. The cells were preincubated 
with 10% bovine seum albumin in PBS for 1 hour at 37°C 
before exposure to primary antibodies overnight at 4°C. 
Immunostaining was carried out using guinea-pig derived 
anti-rat GABAB1R antibody (1 : 500, 24 hours, 4°C, Santa 
Cruz Biotechnology), rabbit anti-rat PKA-α antibody (1 : 500, 
Santa Cruz Biotechnology), or rabbit anti-rat anti-p-CREB 
antibody (1 : 500, Cell Signaling). Following incubation, cells 
were washed and secondary antibodies applied as follows: 
anti-rabbit IgG-TRITC and -FITC conjugated antibodies, 1 : 
100; anti-guinea pig IgG-FITC conjugate, 1 : 150 (both from 
DAKOCytomation, Glostrup, Denmark). For co-staining, 
incubations were performed in parallel. Glass cover-slips were 
affixed to slides with mounting medium. Imaging was performed 
with a fluorescence microscope (Zeiss, Jena, Germany) or 
confocal microscope (Olympus, Tokyo, Japan), and images 
captured with a soft imaging systems video camera.
Results
Alterations in GABAB1R mRNA expression con  comi-
tant with ET and siRNA transfection
To investigate whether ethanol can modulate GABAB1R 
expression, we observed the changes in GABAB1R expression Ethanol-mediated stimulation of GABAB receptor
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levels induced by ET on cultured GD 17.5 rat hippocampal 
neurons. GABAB1R mRNA levels were decreased by ET, but 
increased by baclofen treatment (BT) or phaclofen treatment 
(PT). Transfection of siRNA complementary to endogenous 
GABAB1R mRNA led to its efficient destruction, while β-actin 
levels were unchanged (Fig. 1).
Alterations in protein expression of GABAB1R, PKA- 
α, CaMKII and p-CREB concomitant with ET and 
siRNA transfection
We wished to ascertain whether ET-mediated transcrip-
tional alterations affected protein levels in cultured GD 17.5 
rat hippocampal neurons. Western blotting results showed 
that GABAB1R protein levels were increased by ET in vitro, 
but this effect was reversed by PT. BT potentiated the effect 
of ethanol on GABAB1R expression (Fig. 2). In contrast, no 
remarkable change in PKA-α level was observed under ET 
or PT in vitro (Fig. 3). Because PKA-α levels were unchanged 
upon GABAB1R knockdown, as well as BT and PT, we 
speculated that CaMKII might instead regulate p-CREB. 
Ethanol decreased CaMKII expression in GD 17.5 rat hip-
pocampal neurons, whereas BT, PT, and baclofen plus 
phaclofen treatment (BPT) reversed these effects; BT, PT, 
and BPT significantly decreased CaMKII expression upon 
siRNA knockdown of GABAB1R (Fig. 4). p-CREB protein 
levels were decreased by ET, an effect reversed by BT, PT 
did not alter protein expression. We additionally probed 
whether ethanol-induced changes in GABAB1R expression 
affected its intracellular signal transduction, knocking down 
its expression by RNAi to that end. GABAB1R knockdown 
reduced all of p-CREB expression level (Fig. 5).
Fig. 1. (A) Reverse transcription polymerase chain reaction analyses 
of GABAB1R mRNA expression with ethanol treatment, baclofen 
treatment, phaclofen treatment, or baclofen plus phaclofen treatment, 
and with or without GABAB1R siRNA transfection, in cultured rat 
gestational day 17.5 hippocampal neurons. All groups were incubated 
for 20 min with each drug. (B) Densitometry measurements of 
GABAB1R bands in (A). The density values on (Y-axis) were expressed 
as arbitrary units (AU). N, normal media as control; E, treated with 
100 mM ethanol; B, 50 mM baclofen; P, 100 mM phaclofen; BP, 50 μM 
baclofen plus 100 mM phaclofen. With GABAB1R siRNA transfection: 
TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM 
baclofen; TP, 100 mM phaclofen; TBP, 50 mM baclofen plus 100 mM 
phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected 
group.
Fig. 2. (A) Western blot analyses of GABAB1R protein levels with 
ethanol treatment, baclofen treatment, phaclofen treatment, or 
baclofen plus phaclofen treatment, and with or without GABAB1R 
siRNA transfection in cultured rat gestational day 17.5 hippocampal 
neurons. All groups were incubated for 20 min with each drug. (B) 
Densitometry measurements of GABAB1R bands in (A). The density 
values on (Y-axis) were expressed as arbitrary units (AU). N, normal 
media as control; E, treated with 100 mM ethanol; B, 50 mM baclofen; 
P, 100 μM phaclofen; BP, 50 mM baclofen plus 100 mM phaclofen. 
With GABAB1R siRNA transfection: TN, normal media as control; 
TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; 
TBP, 50 mM baclofen plus 100 mM phaclofen; GABA, γ-aminobutyric 
acid. *P<0.05 in nontransfected group, 
†P<0.05 in transfected group.Anat Cell Biol 2011;44:210-217 Hae Young Lee, et al 214
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Co-localization of GABAB1R, p-CREB, and changes in 
distribution with siRNA transfection
To confirm the localization of GABAB1R and p-CREB, 
and to determine changes mediated by siRNA knockdown of 
GABAB1R, we performed immunofluorescence assays on GD 
17.5 rat hippocampal neurons. GABAB1R co-localized with 
p-CREB in hippocampal neuronal cytoplasm and p-CREB 
distribution was reduced by GABAB1R siRNA (Fig. 6).
Together, these results demonstrate that ethanol can mo-
dulate phosphorylation of CREB via PKA-α or CaMKII 
pathway intracellular Ca
2+ dependently, which is linked to 
GABAB1R activation in prenatal hippocampal neurons (Fig. 7).
Discussion
In this study, we have endeavored to characterize altera-
tions to GABABR, PKA-α, and p-CREB expression in res-
ponse to ET in cultured hippocampal neurons. We have 
ad  ditionally tested the modulatory effects of a GABAB1R 
agonist and/or antagonist on ET-mediated GABA-ergic 
signaling, as well as that of GABAB1R gene knockdown. We 
find that ethanol regulates GABABR expression disparately 
at mRNA and protein levels, suggesting that these effects are 
not completely attributable to changes in gene expression as 
previously mentioned [21].
Ethanol increased GABAB1R protein expression, but de-
creased that of PKA-α and p-CREB, in our study. Previous 
research has demonstrated that ET reduces hippocampal 
p-CREB protein levels in a manner reversible upon its with-
drawal [22]; however, there is some contention over these 
findings, as other work has found that chronic ethanol 
Fig. 3. (A) Western blot analyses of protein kinase A (PKA)-a protein 
levels with ethanol treatment, baclofen treatment or phaclofen 
treatment and with or without GABAB1R siRNA transfection in 
cultured rat gestational day 17.5 hippocampal neurons. All groups were 
incubated for 20 min with each drug. (B) Densitometry measurements 
of PKA-a bands in (A). The density values on (Y-axis) were expressed 
as arbitrary units (AU). N, normal media as control; E, treated with 
100 mM ethanol; B, 50 μM baclofen; P, 100 mM phaclofen; With 
GABAB1R siRNA transfection: TN, normal media as control; TE, 100 
mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; GABA, 
γ-aminobutyric acid. *P<0.05 in nontransfected group, 
†P<0.05 in 
transfected group.
Fig. 4. (A) Western blot analyses of calcium/calmodulin-dependent 
protein kinase II (CaMKII) protein levels with ethanol treatment, 
baclofen treatment, phaclofen treatment, or baclofen plus phaclofen 
treatment, and with or without GABAB1R siRNA transfection in 
cultured rat gestational day 17.5 hippocampal neurons. All groups were 
incubated for 20 min with each drug. (B) Densitometry measurements 
of CaMKII bands in A. The density values on (Y-axis) were expressed 
as arbitrary units (AU).  N, normal media as control; E, treated with 
100 mM ethanol; B, 50 μM baclofen; P, 100 mM phaclofen; BP, 50 μM 
baclofen plus 100 mM phaclofen. With GABAB1R siRNA transfection: 
TN, normal media as control; TE, 100 mM ethanol; TB, 50 mM 
baclofen; TP, 100 mM phaclofen; TBP, 50 mM baclofen plus 100 mM 
phaclofen; GABA, γ-aminobutyric acid. *P<0.05 in nontransfected 
group, 
†P<0.05 in transfected group.Ethanol-mediated stimulation of GABAB receptor
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treatment (CET) may decrease long-term potentiation in 
the hippocampus through reduction in presynaptic GABAB 
autoreceptor, and CET decreases GABABR expression 
consistent with increased GABA release [23]. Additionally, 
PKA and p-CREB protein expression were significantly 
lower in the hippocampi of model rats experiencing chronic, 
unpredicted, mild stress than in normal control animals [24], 
and alcohol-preferring rats that exhibit increased ethanol 
consumption likewise increase p-CREB expression selectively 
in the central amygdala after acute ET. Thus, it has been 
assumed that ethanol-induced reduction in GABAB1R levels 
stems from tolerance to ET in vivo [25]. 
We determined that p-CREB levels were decreased by 
ET in vitro, and that this decrease could be counteracted by 
BT. These findings agreed with previous reports that chronic 
binge ethanol administration results in neurodegeneration 
of the hippocampal dentate gyrus, reduced neurogenesis, 
decreases in p-CREB, decreased expression of pro-survival 
genes, and increased vulnerability to insults and neuronal 
death. Also, drug-induced CREB inactivation may lead to 
hippocampal neurotoxicity [26]. Several studies indicate that 
baclofen may reduce ethanol intake [14-17], and preclinical 
and clinical research has evaluated the potential of GABABR 
subtype agonists as pharmacotherapy for substance abuse, 
including that of ethanol. Baclofen contributes significantly to 
neuroprotection against ischemia in organotypic hippocampal 
slices [27]. However, the detailed molecular mechanisms for 
modulation by ethanol of GABABR signal transduction will 
require more thorough investigation.
To further confirm the modulatory effects of ET on 
GABABR, we knocked down GABAB1R expression by RNAi 
and examined the hippocampal responses to ethanol in vitro. 
The same effects were observed with BT, PT, and BPT after 
RNAi against GABAB1R. GABAB suppresses neurotransmitter 
release via inhibition of Ca
2+ channels [28], and our results 
demonstrated a similar trend upon direct ethanol exposure. 
Activation of presynaptic GABABR at certain synapses can 
inhibit adenylyl cyclase, thereby decreasing cAMP levels and 
PKA activity to result in suppression of GABA release [29-
31]. GABABR stimulation also signals to effectors through 
the G protein βγ subunit; βγ-mediated signaling includes the 
activation of G protein coupled inwardly rectifying potassium 
channels and the inhibition of voltage-gated calcium channels 
[32]. Since PKA-α and CaMKII can diffuse into the nucleus 
and phosphorylate CREB at the same serine residue, it is 
possible that GABABR and calmodulin kinase engage in 
crosstalk. 
In conclusion, we studied alterations in GABAB1R and 
intracellular signaling factor expression upon ET in cultured 
rat hippocampal neurons. Ethanol reduced p-CREB levels in 
the presence of functional GABAB1R, but RNAi knockdown 
of GABAB1R or BT treatment reversed this effect. GABABR 
therefore can modulate p-CREB expression in the nucleolus 
through either PKA-α or CaMKII.
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Fig. 5. Western blot analyses of phosphorylation of cAMP-response 
element binding protein (p-CREB) protein levels with ethanol 
treatment, baclofen treatment, phaclofen treatment, or baclofen 
plus phaclofen treatment, and with or without GABAB1R siRNA 
transfection in cultured rat gestational day 17.5 hippocampal 
neurons. All groups were incubated for 20 min with each drug. (B) 
Densitometry measurements of p-CREB bands in (A). The density 
values on (Y-axis) were expressed as arbitrary units (AU). N, normal 
media as control; E, treated with 100 mM ethanol; B, 50 mM baclofen; 
P, 100 mM phaclofen; BP, 50 mM baclofen plus 100 mM phaclofen. 
With GABAB1R siRNA transfection: TN, normal media as control; 
TE, 100 mM ethanol; TB, 50 mM baclofen; TP, 100 mM phaclofen; 
TBP, 50 mM baclofen plus 100 mM phaclofen; GABA, γ-aminobutyric 
acid. *P<0.05 in nontransfected group, 
†P<0.05 in transfected group.Anat Cell Biol 2011;44:210-217 Hae Young Lee, et al 216
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